RNAZ

Transcode Therapeutics, Inc.

Healthcare · Biotechnology

$76.80 sample

+0.84 (+1.11%) 1D

Market cap

$373.8B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-06

Alerts

8

Price$76.80 +14.71% 3M daily closessample

76.8065.77

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: General Counsel
Sep 21INSInsider sell: EVP, Operations
Sep 14INSInsider sell: EVP, Operations
Sep 09INSInsider sell: Chief Executive Officer
Sep 02INSInsider buy: Director
Aug 25INSInsider sell: Director
Aug 17INSInsider sell: EVP, Operations
Aug 06SEC10-Q filed

Sign up to see the real RNAZ record →

Company facts

SEC EDGAR registration

Name: Transcode Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +59sample, -100 to +100
Reporting currency: USD

Who is positioning in RNAZ

sample

Insiders: 22 insider transactions over 90 days, net selling, $699.1M
Congress: No member trades over 90 days
Institutions · 13F: 17 funds hold $7.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.6B +13.8% y/y

Q4 2024Q3 2026

Inventory$7.8B +12.5% y/y

Q4 2024Q3 2026

Accounts receivable$5.7B +15.9% y/y

Q4 2024Q3 2026

Total debt$15.1B +12.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $359.4B -5.2% 3M
Sample peer B: $340.6B +5.8% 3M
Sample peer C: $243.1B -7.1% 3M
Sample peer D: $141.6B -6.1% 3M
Sample peer E: $149.2B +1.6% 3M